Considering glioblastoma is specifically defined as having wild-type IDH1, the upregulation of IDH1 but not IDH2 in this study is likely due to increased mutant IDH2 expression over wild-type IDH2 normally seen in the presence of wild-type IDH1. Here, IDH1 is linked to glioblastoma.